Skip to content
Promethazine hydrochloride and dextromethorphan hydrobromide, Nuedexta(dextromethorphan)
Auvelity, Bromanate, Bromfed-dm, Dimetane-dx, Mucinex, Nuedexta, Pherazine (dextromethorphan) is a small molecule pharmaceutical. Dextromethorphan was first approved as Promethazine hydrochloride and dextromethorphan hydrobromide on 1984-04-02. It is used to treat cough in the USA. It has been approved in Europe to treat neurobehavioral manifestations. It is known to target sigma non-opioid intracellular receptor 1 and glutamate receptor ionotropic, NMDA 2C.
Download report
Favorite
SARS-CoV-2 Interaction
Top OTC Drugs
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
nervous system diseasesD009422
signs and symptoms pathological conditionsD013568
behavior and behavior mechanismsD001520
Trade Name
FDA
EMA
Combinations
Auvelity, Mucinex, Nuedexta (generic drugs available since 1985-01-04, discontinued: Bromanate, Bromfed-dm, Dimetane-dx, Pherazine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Brompheniramine maleate
+
Dextromethorphan hydrobromide
+
Pseudoephedrine hydrochloride
Tradename
Company
Number
Date
Products
DIMETANE-DXA.H. Robins CompanyN-019279 DISCN1984-08-24
1 products, RLD
Hide discontinued
Bupropion hydrochloride
+
Dextromethorphan hydrobromide
Tradename
Company
Number
Date
Products
AUVELITYAxsome MaltaN-215430 RX2022-08-18
1 products, RLD, RS
Dextromethorphan hydrobromide
+
Guaifenesin
Tradename
Company
Number
Date
Products
MUCINEX DMRB HealthN-021620 OTC2004-04-29
2 products, RLD
Dextromethorphan hydrobromide
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDEANI PHARMSN-011265 DISCN1984-04-02
1 products, RLD
Hide discontinued
Dextromethorphan hydrobromide
+
Quinidine sulfate
Tradename
Company
Number
Date
Products
NUEDEXTAAvanir PharmaceuticalsN-021879 RX2010-10-29
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
auvelityNew Drug Application2022-09-02
mucinex fast-max day cold and flu and night cold and fluOTC monograph final2023-06-15
nuedextaNew Drug Application2022-11-30
severe cold and flu reliefOTC monograph final2023-06-19
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
coughHP_0012735D003371R05
Agency Specific
FDA
EMA
Expiration
Code
BUPROPION HYDROCHLORIDE / DEXTROMETHORPHAN HYDROBROMIDE, AUVELITY, AXSOME
2025-08-18NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Bupropion Hydrochloride / Dextromethorphan Hydrobromide, Auvelity, Axsome
107800642040-01-07U-3419
109258422040-01-07U-3419
109401242040-01-07U-3419
109669422040-01-07U-3419
107800662034-11-09U-3419
91682342034-11-05U-3419
91989052034-11-05U-3419
92050832034-11-05U-3419
92380322034-11-05U-3419
92780952034-11-05U-3419
93144622034-11-05U-3419
93705132034-11-05U-3419
93754292034-11-05U-3419
94088152034-11-05U-3419
94211762034-11-05U-3419
94570232034-11-05U-3419
94570252034-11-05U-3419
94747312034-11-05U-3419
94864502034-11-05U-3419
97005282034-11-05U-3419
97005532034-11-05U-3419
97071912034-11-05U-3419
97639322034-11-05U-3419
98615952034-11-05U-3419
98678192034-11-05U-3419
99685682034-11-05U-3419
100585182034-11-05U-3419
100648572034-11-05U-3419
100807272034-11-05U-3419
100925602034-11-05U-3419
100925612034-11-05U-3419
101053272034-11-05U-3419
101053612034-11-05U-3419
102518792034-11-05U-3419
104636342034-11-05U-3419
105126432034-11-05U-3419
105488572034-11-05U-3419
105961672034-11-05U-3419
107728502034-11-05U-3419
107864692034-11-05U-3419
107864962034-11-05U-3419
107994972034-11-05U-3419
108067102034-11-05U-3419
108642092034-11-05U-3419
108746632034-11-05U-3419
108746642034-11-05U-3419
108746652034-11-05U-3419
108816242034-11-05U-3419
108816572034-11-05U-3419
108940462034-11-05U-3419
108940472034-11-05U-3419
108984532034-11-05U-3419
109330342034-11-05U-3419
109459732034-11-05U-3419
109669412034-11-05U-3419
109669742034-11-05U-3419
110203892034-11-05U-3419
110586482034-11-05U-3419
110903002034-11-05U-3419
110969372034-11-05U-3419
111233432034-11-05U-3419
111298262034-11-05U-3419
111413882034-11-05U-3419
111414162034-11-05U-3419
111478082034-11-05U-3419
111855152034-11-05U-3419
111917392034-11-05DPU-3419
111978392034-11-05DPU-3419
112072812034-11-05U-3419
112135212034-11-05U-3419
112296402034-11-05U-3419
112349462034-11-05U-3419
112534912034-11-05U-3419
112534922034-11-05U-3419
112731332034-11-05U-3419
112731342034-11-05U-3419
112851182034-11-05U-3419
112851462034-11-05U-3419
112916382034-11-05U-3419
112916652034-11-05U-3419
112983512034-11-05U-3419
112983522034-11-05U-3419
113115342034-11-05U-3419
113445442034-11-05U-3419
113577442034-11-05U-3419
113642332034-11-05U-3419
113828742034-11-05U-3419
114198672034-11-05U-3419
114263702034-11-05U-3419
114264012034-11-05U-3419
114330672034-11-05DPU-3419
114396362034-11-05U-3419
114784682034-11-05U-3419
114977212034-11-05U-3419
115109182034-11-05U-3419
115175422034-11-05U-3419
115175432034-11-05U-3419
115240072034-11-05U-3419
115240082034-11-05U-3419
115344142034-11-05DPU-3419
115410212034-11-05U-3419
115410482034-11-05U-3419
115966272034-11-05U-3419
116177282034-11-05U-3419
116177472034-11-05U-3563
85693282033-10-29DPU-3419
Dextromethorphan Hydrobromide / Quinidine Sulfate, Nuedexta, Avanir Pharms
76592822026-08-13U-1093
82274842023-07-17U-1093
ATC Codes
N: Nervous system drugs
N07: Other nervous system drugs in atc
N07X: Other nervous system drugs in atc
N07XX: Other nervous system drugs in atc
N07XX59: Dextromethorphan, combinations
R: Respiratory system drugs
R05: Cough and cold preparations
R05D: Cough suppressants, excl. combinations with expectorants
R05DA: Opium alkaloids and derivatives, cough suppressants
R05DA09: Dextromethorphan
HCPCS
No data
Clinical
Clinical Trials
166 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients2911435
CoughD003371HP_0012735R0523117
Major depressive disorderD003865EFO_0003761F2223116
Alzheimer diseaseD000544EFO_0000249F0321216
Respiratory tract infectionsD012141J06.911326
Pseudobulbar palsyD020828EFO_1001131134
Postoperative painD010149G89.18213
Common coldD003139EFO_0007214J001113
StrokeD020521EFO_0000712I63.91113
BronchitisD001991J40123
Show 11 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C803115
Treatment-resistant depressive disorderD0612181314
Rett syndromeD015518F84.22114
Amyotrophic lateral sclerosisD000690EFO_0000253G12.211213
SchizophreniaD012559EFO_0000692F202213
Parkinson diseaseD010300EFO_0002508G20213
PainD010146EFO_0003843R521113
Huntington diseaseD006816G10112
Bipolar disorderD001714EFO_0000289F30.922
Multiple sclerosisD009103EFO_0003885G35112
Show 13 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeuralgiaD009437EFO_000943055
HyperalgesiaD006930123
FibromyalgiaD005356EFO_0005687M79.1112
Spinal cord injuriesD013119EFO_100191922
Type 2 diabetes mellitusD003924EFO_0001360E1122
Smoking cessationD016540EFO_0004319111
Migraine disordersD008881EFO_0003821G4311
Brain edemaD001929EFO_1000845G93.611
DyskinesiasD020820G2411
Autistic disorderD001321EFO_0003758F84.011
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug interactionsD004347213
Food-drug interactionsD01856522
Prostatic neoplasmsD011471C6122
InfectionsD007239EFO_0000544112
MelanomaD00854511
Mitochondrial diseasesD028361EFO_000059111
Therapeutic equivalencyD01381011
PsoriasisD011565EFO_0000676L4011
Voice disordersD01483211
Mucociliary clearanceD00907911
Show 1 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.911
Attention deficit disorder with hyperactivityD001289EFO_0003888F9011
Breast neoplasmsD001943EFO_0003869C5011
Pituitary dwarfismD004393EFO_1001109E23.011
Sleep apnea syndromesD012891EFO_0003877G47.311
Neurotoxicity syndromesD020258G9211
FatigueD005221HP_0012378R53.8311
PneumoniaD011014EFO_0003106J1811
Lung diseasesD008171EFO_0003818J98.411
Pulmonary fibrosisD011658J84.1011
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDEXTROMETHORPHAN
INNdextromethorphan
Description
Dextromethorphan is a 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene in which the sterocenters at positions 4a, 10 and 10a have S-configuration. It is a prodrug of dextrorphan and used as an antitussive drug for suppressing cough. It has a role as a NMDA receptor antagonist, a neurotoxin, a xenobiotic, an environmental contaminant, an antitussive, a prodrug and a oneirogen. It is functionally related to a dextrorphan. It is an enantiomer of a levomethorphan.
Classification
Small molecule
Drug classdeuterated compounds; narcotic antagonists/agonists (morphinan derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3
Identifiers
PDB
CAS-ID125-71-3
RxCUI3289
ChEMBL IDCHEMBL52440
ChEBI ID
PubChem CID5360696
DrugBankDB00514
UNII ID7355X3ROTS (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
SIGMAR1
SIGMAR1
GRIN2C
GRIN2C
Organism
Homo sapiens
Gene name
SIGMAR1
Gene synonyms
OPRS1, SRBP
NCBI Gene ID
Protein name
sigma non-opioid intracellular receptor 1
Protein synonyms
Aging-associated gene 8 protein, hSigmaR1, SIG-1R, Sigma 1-type opioid receptor, Sigma1-receptor, Sigma1R, SR-BP, SR31747 binding protein 1, SR31747-binding protein
Uniprot ID
Mouse ortholog
Sigmar1 (18391)
sigma non-opioid intracellular receptor 1 (O55242)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 6,057 documents
View more details
Safety
Black-box Warning
Black-box warning for: Auvelity
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
97,043 adverse events reported
View more details